Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model

Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model

<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...

書誌詳細
第一著者:	Anderson, R
その他の著者:	Vallis, K
フォーマット:	学位論文
言語:	English
出版事項:	2021
主題:	Oncology

類似資料

Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
著者:: REN Ya'nan, 等
出版事項: (2020-12-01)

Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
著者:: Solmaz Mojarad-Jabali, 等
出版事項: (2025-01-01)

Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
著者:: P. August Schubiger, 等
出版事項: (2004-10-01)

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
著者:: Paweł Szponar, 等
出版事項: (2023-11-01)

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
著者:: Alessio Rizzo, 等
出版事項: (2022-11-01)

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer
著者:: Erolcan Sayar, 等
出版事項: (2023-04-01)

The role of fibroblast ENPP1 expression on anti-tumour immunity
著者:: Vadibeler, S
出版事項: (2023)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
著者:: Jackson, M
出版事項: (2013)

Radionuclide imaging of angiogenesis
著者:: Patel, N
出版事項: (2013)

Editorial for the Special Issue “Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design”
著者:: Carlo Aprile, 等
出版事項: (2024-03-01)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
著者:: Eline A.M. Ruigrok, 等
出版事項: (2019-10-01)

Radiopharmaceuticals from generator-produced radionuclides
著者:: International Atomic Energy Agency
出版事項: (1971)

Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy
著者:: Royle, G
出版事項: (2016)

DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review
著者:: Luca Filippi, 等
出版事項: (2022-12-01)

Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
著者:: Suliman Salih, 等
出版事項: (2022-08-01)

Role of delta-like 4 in solid tumours and response to radiation therapy
著者:: Bham, S
出版事項: (2013)

Regulated antagonism of immune suppressive molecules in tumours
著者:: Alamoudi, A
出版事項: (2014)

Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology
著者:: Katsumi Tomiyoshi, 等
出版事項: (2024-11-01)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
著者:: Welch, Michael J.
出版事項: (1977)

Innovative Development of Reactor-Produced Radionuclides and Radiopharmaceuticals
著者:: Peng Shuming, 等
出版事項: (2024-04-01)

Radiopharmaceutical Validation for Clinical Use
著者:: Charles A. Kunos, 等
出版事項: (2021-03-01)

PSMA-targeted therapy for non-prostate cancers
著者:: Jarey H. Wang, 等
出版事項: (2023-08-01)

Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
著者:: Hanane Lahnif, 等
出版事項: (2021-10-01)

Advances in <sup>177</sup>Lu-PSMA and <sup>225</sup>Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
著者:: Sui Wai Ling, 等
出版事項: (2022-10-01)

USE OF <sup>177</sup>Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
著者:: A. A. Medvedeva, 等
出版事項: (2021-06-01)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
著者:: Nicolas Lepareur, 等
出版事項: (2025-02-01)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
著者:: Druce, MR, 等
出版事項: (2010)

Development of Radiopharmaceutical Composition for Radionuclide Diagnostics of Malignant Melanoma
著者:: O. E. Klementyeva, 等
出版事項: (2020-11-01)

Editorial: Production of novel medical radionuclides and innovative radiopharmaceuticals
著者:: Susanta Lahiri, 等
出版事項: (2024-02-01)

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
著者:: Burcu Altıparmak Güleç, 等
出版事項: (2021-07-01)

Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals
著者:: Alberto Miceli, 等
出版事項: (2024-05-01)

Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy
著者:: Louise Emmett, 等
出版事項: (2017-03-01)

Targeting radioresistance and replication fork stability in prostate cancer
著者:: Xiangyi Li, 等
出版事項: (2022-05-01)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
著者:: Nat P. Lenzo, 等
出版事項: (2018-02-01)

Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
著者:: Miriam Conte, 等
出版事項: (2023-03-01)

Activities, procedures and doses in pediatric patients due to radiopharmaceuticals
著者:: Silvia Maria Velasques de Oliveira, 等
出版事項: (2008-12-01)

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
著者:: Peter Zanvit, 等
出版事項: (2023-11-01)

Lutathera<sup>®</sup>: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
著者:: Ute Hennrich, 等
出版事項: (2019-07-01)

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
著者:: André H. Dias, 等
出版事項: (2023-04-01)

Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α<sub>v</sub>β<sub>3</sub>-Targeted Radionuclide Therapy
著者:: Guangjie Yang, 等
出版事項: (2022-06-01)